Pharmaceutical

Genentech and NVIDIA enter generative AI-powered drug d...

Roche Group member Genentech has entered a multi-year strategic generative arti...

Opinion: What Rosalynn Carter understood about mental h...

What Rosalynn Carter understood about mental health.

How the shakeup at OpenAI underscores the need for AI s...

Industry insiders worry about the risk of too much power resting with a couple o...

STAT+: House Republicans call CDC director to testify

House Republicans are calling in CDC Director Mandy Cohen to testify about publi...

STAT+: Prominent pharmaceutical industry ally Anna Esho...

Rep. Anna Eshoo's retirement will be yet another loss of a Democratic champion f...

STAT+: Sen. Bernie Sanders publicly pressures Merck, J&...

Sen. Bernie Sanders is publicly pressuring Merck, J&J, and Bristol Myers Squibb ...

Bayer’s new CEO was dealt a duo of ‘clearing events.’ T...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Texas sues Pfizer over ADHD drugs;...

The Texas attorney general is suing Pfizer over allegedly selling ineffective AD...

STAT+: Flagship Pioneering launches Quotient, a new bio...

Flagship Pioneering, the venture capital firm behind Moderna, unveiled a new bio...

STAT+: Mixed study results for MorphoSys blood-cancer d...

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target...

STAT+: How the CEO of the largest medical device accele...

MedTech Innovator is creating a vibrant community of innovators, injecting a you...

Opinion: Filling 12-month prescriptions is one practica...

Getting a year’s worth of a maintenance medication in one visit makes life easie...

Invisible in the data: Broad ‘Asian American’ category ...

Blending together the highly diverse pool of Asian Americans in widely used metr...

STAT+: Delay of eye drop recall highlights FDA’s impote...

It took the FDA a while to coax companies to take certain eye drops off shelves....

STAT+: Pharmalittle: CRISPR pioneers reflect on future ...

The U.K. and the pharma industry reached a deal on a five-year plan outlining ho...

Merck cough drug doesn’t pass panel scrutiny

Want to stay on top of the science and politics driving biotech today? Sign up t...